#drug experiments

Upon experiencing my first Imperial late event, here are a few things that I learnt: 

- My first lecture focused on precision polymer particles by Professor Rachel O’riley. Although typically such nanoparticles are governed by the ratio of hydrophobic and hydrophilic components for self assembly, here; the focus was on crystallisation driven self assembly (CDSA) which overrides this mechanism. DMA seeds are used as the original seeds on which the polymer begins to form through a process known as living polymerisation growth for greater control that leads to platelet like structures. Studying the complexity of assembly was important on exploring how polymer length, composition and chemistry can be altered to rationally tune nanoparticle shape and in turn it’s properties. Novel applications include directing biological interactions, such as cellular uptake, intracellular trafficking and immune response or the ability to modulate hydrogel mechanical and adhesion properties when used as fillers for antimicrobial and tissue engineering purposes. 

- The second talk event was lead by Dr Catherine Kibirige on treating HIV in rural African communities. HIV is particularly difficult to treat and has to be rather suppressed because of it’s elusion from the immune system. Using a continually shifting shield of glycans, it prevent antibodies from detecting and attacking. It also replicates rapidly using reverse transcriptase to develop a pool of diverse HIV strains - called quasi-species - whilst attacking helper T-cells that orchestrate the immune system’s cell signalling. Finally it has a long incubation period and is slow to reveal (typically 5-10 years), where by that point it may have shredded the victims immune system. There are campaigns that have been developed, notably the ongoing UN led campaign of 95-95-95; where 95% people with HIV know their status, then 95% are receiving their treatment and 95% have suppressed their viral load by 2030. Suppression is the best we have at the current moment with no vaccine, with the Undetectable= Untransmittable campaign (U=U), sexual transmissions of HIV can be stopped by lowering the viral load in blood whilst on effective treatment. Dr Kibirige has been a part of the HIVQuant project that is a HIV-1 kit (working on portable solar or battery driven cyclers) that provides a treatment monitoring solution for resource-constrained settings, especially in Africa to minimise monthly hourly trips to district hospitals to meet the 2030 95-95-95 UN target. 

It appears that the fine folks at NASA have nothing better to do with U.S. tax dollars than test the side effects of various drugs on the web designing techniques of spiders.  Badspiderbites.com provides an interactive video so you can see for yourself what a spider's web would look like on Mescaline, Hash, LSD, and even caffeine.